Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 5.
Article
Cook, R;
Zoumpoulidou, G;
Luczynski, MT;
Rieger, S;
Moquet, J;
Spanswick, VJ;
Hartley, JA;
... Mittnacht, S; + view all
(2015)
Direct Involvement of Retinoblastoma Family Proteins in DNA Repair by Non-homologous End-Joining.
Cell Rep
, 10
(12)
2006 - 2018.
10.1016/j.celrep.2015.02.059.
|
Goncalves, T;
Zoumpoulidou, G;
Alvarez-Mendoza, C;
Mancusi, C;
Collopy, LC;
Strauss, SJ;
Mittnacht, S;
(2020)
Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.
ACS Pharmacology & Translational Science
, 3
(6)
pp. 1253-1264.
10.1021/acsptsci.0c00125.
|
Meijles, DN;
Zoumpoulidou, G;
Markou, T;
Rostron, KA;
Patel, R;
Lay, K;
Handa, BS;
... Clerk, A; + view all
(2019)
The cardiomyocyte “redox rheostat”: Redox signalling via the AMPK-mTOR axis and regulation of gene and protein expression balancing survival and death.
Journal of Molecular and Cellular Cardiology
, 129
pp. 118-129.
10.1016/j.yjmcc.2019.02.006.
|
Stockwell, SR;
Platt, G;
Barrie, SE;
Zoumpoulidou, G;
Te Poele, RH;
Aherne, GW;
Wilson, SC;
... Mittnacht, S; + view all
(2012)
Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signalling.
PLOS One
, 7
(1)
, Article e28568. 10.1371/journal.pone.0028568.
|
Zoumpoulidou, G;
Alvarez-Mendoza, C;
Mancusi, C;
Ahmed, R-M;
Denman, M;
Steele, CD;
Tarabichi, M;
... Mittnacht, S; + view all
(2021)
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.
Nature Communications
, 12
(1)
, Article 7064. 10.1038/s41467-021-27291-8.
|